Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All HCQ studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19hcq.org COVID-19 treatment researchHCQHCQ (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study

Gautret et al., Travel Medicine and Infectious Disease, doi:10.1016/j.tmaid.2020.101663
Apr 2020  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
HCQ for COVID-19
1st treatment shown to reduce risk in March 2020
 
*, now with p < 0.00000000001 from 411 studies, recognized in 46 countries.
No treatment is 100% effective. Protocols combine treatments. * >10% efficacy, ≥3 studies.
4,300+ studies for 75 treatments. c19hcq.org
Pilot study suggesting improvement with HCQ+AZ and recommending further study. 80 patients with relatively mild cases, no control group, and no attempt to analyze confounding factors.
Gautret et al., 11 Apr 2020, peer-reviewed, 29 authors, average treatment delay 4.8 days.
This PaperHCQAll
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
Philippe Gautret, Jean-Christophe Lagier, Philippe Parola, Van Thuan Hoang, Line Meddeb, Jacques Sevestre, Morgane Mailhe, Barbara Doudier, Camille Aubry, Sophie Amrane, Piseth Seng, Marie Hocquart, Carole Eldin, Julie Finance, Vera Esteves Vieira, Hervé Tissot Tissot-Dupont, Stéphane Honoré, Andreas Stein, Matthieu Million, Philippe Colson, Bernard La Scola, Véronique Veit, Alexis Jacquier, Jean-Claude Deharo, Michel Drancourt, Pierre Edouard Fournier, Jean-Marc Rolain, Philippe Brouqui, Didier Raoult
Travel Medicine and Infectious Disease, doi:10.1016/j.tmaid.2020.101663
Background: We need an effective treatment to cure COVID-19 patients and to decrease virus carriage duration. Methods: We conducted an uncontrolled, non-comparative, observational study in a cohort of 80 relatively mildly infected inpatients treated with a combination of hydroxychloroquine and azithromycin over a period of at least three days, with three main measurements: clinical outcome, contagiousness as assessed by PCR and culture, and length of stay in infectious disease unit (IDU). Results: All patients improved clinically except one 86 year-old patient who died, and one 74 year-old patient still in intensive care. A rapid fall of nasopharyngeal viral load was noted, with 83% negative at Day7, and 93% at Day8. Virus cultures from patient respiratory samples were negative in 97.5% of patients at Day5. Consequently patients were able to be rapidly discharged from IDU with a mean length of stay of five days. Conclusion: We believe there is urgency to evaluate the effectiveness of this potentially-life saving therapeutic strategy at a larger scale, both to treat and cure patients at an early stage before irreversible severe respiratory complications take hold and to decrease duration of carriage and avoid the spread of the disease. Furthermore, the cost of treatment is negligible.
Appendix A. Supplementary data Supplementary data to this article can be found online at https:// doi.org/10.1016/j.tmaid.2020.101663.
References
Amrane, Tissot-Dupont, Doudier, Eldin, Hocquart et al., Rapid viral diagnosis and ambulatory management of suspected COVID-19 cases presenting at the infections diseases referral hospital in Marseille, France, -January 31st to March 1st, 2020: a respiratory virus snapshot, Trav Med Infect Dis
Chatre, Roubille, Vernhet, Jorgensen, Pers, Cardiac complications attributed to chloroquine and hydroxychloroquine: a systematic review of the literature, Drug Saf
Chen, Hu, Zo, Jiang, Han et al., Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial, MedRxiv, doi:10.1101/2020.03.22.20040758
Chen, Liu, Liu, Liu, Xu et al., A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19
Colson, Rolain, Lagier, Brouqui, Raoult, Chloroquine and hydroxychloroquine as available weapons to fight COVID-19, Int J Antimicrob Agents
Colson, Rolain, Raoult, Chloroquine for the 2019 novel coronavirus SARS-CoV-2, Int J Antimicrob Agents
Corman, Landt, Kaiser, Molenkamp, Meijer et al., Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR, Euro Surveill
Gao, Tian, Yang, Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies, Biosci Trends
Gautret, Lagier, Parola, Hoang, Meddeb et al., Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, Int J Antimicrob Agents
Hicks, Th, Hunkler, outpatient antibiotic prescribing, 2010, N Engl J Med
Lai, Shih, Ko, Tang, Hsueh, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges, Int J Antimicrob Agents
Liao, Wang, Kang, Novel coronavirus infection during the 2019-2020 epidemic: preparing intensive care units-the experience in Sichuan Province, China, Intensive Care Med
Liu, Cao, Xu, Wang, Zhang et al., Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro, Cell Discov
Liu, Yan, Wan, Xiang, Le et al., Viral dynamics in mild and severe cases of COVID-19, Lancet Infect Dis
Mitja, Clotet, Use of antiviral drugs to reduce COVID-19 transmission, Lancet Glob Health
Mo, Yuan, Tao, Peng, Wang, Time kinetics of viral clearance and resolution of symptoms in novel coronavirus infection, Am J Respir Crit Care Med
Nabirothckin, Peluffo, Bouaziz, Cohen, Focusing on the unfolded protein response and autophagy related pathways to reposition common approved drugs against COVID-19, Preprints, doi:10.20944/preprints202003.0302.v1
To, Tsang, Leung, Tam, Wu et al., Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study, Lancet
Wang, Cao, Zhang, Yang, Liu et al., Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro, Cell Res
Wu, Mcgoogan, Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention, J Am Med Assoc
Yao, Ye, Zhang, Cui, Huang et al., In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Clin Infect Dis
Zhou, Dai, Tong, COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression, J Antimicrob Chemother
Zhou, Yu, Du, Fan, Liu et al., Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet
Zhu, Zhang, Li, Yang, Song, A novel coronavirus from patients with pneumonia in China, 2019, N Engl J Med
{ 'indexed': {'date-parts': [[2024, 5, 11]], 'date-time': '2024-05-11T15:11:01Z', 'timestamp': 1715440261866}, 'reference-count': 26, 'publisher': 'Elsevier BV', 'license': [ { 'start': { 'date-parts': [[2020, 3, 1]], 'date-time': '2020-03-01T00:00:00Z', 'timestamp': 1583020800000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}, { 'start': { 'date-parts': [[2021, 5, 8]], 'date-time': '2021-05-08T00:00:00Z', 'timestamp': 1620432000000}, 'content-version': 'am', 'delay-in-days': 433, 'URL': 'http://www.elsevier.com/open-access/userlicense/1.0/'}], 'funder': [ { 'DOI': '10.13039/501100001665', 'name': 'Agence Nationale de la Recherche', 'doi-asserted-by': 'publisher'}], 'content-domain': { 'domain': [ 'clinicalkey.fr', 'clinicalkey.jp', 'clinicalkey.es', 'clinicalkey.com.au', 'clinicalkey.com', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2020, 3]]}, 'DOI': '10.1016/j.tmaid.2020.101663', 'type': 'journal-article', 'created': {'date-parts': [[2020, 4, 11]], 'date-time': '2020-04-11T15:14:50Z', 'timestamp': 1586618090000}, 'page': '101663', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 520, 'title': 'Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in ' '80 COVID-19 patients with at least a six-day follow up: A pilot observational study', 'prefix': '10.1016', 'volume': '34', 'author': [ {'given': 'Philippe', 'family': 'Gautret', 'sequence': 'first', 'affiliation': []}, {'given': 'Jean-Christophe', 'family': 'Lagier', 'sequence': 'additional', 'affiliation': []}, {'given': 'Philippe', 'family': 'Parola', 'sequence': 'additional', 'affiliation': []}, {'given': 'Van Thuan', 'family': 'Hoang', 'sequence': 'additional', 'affiliation': []}, {'given': 'Line', 'family': 'Meddeb', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jacques', 'family': 'Sevestre', 'sequence': 'additional', 'affiliation': []}, {'given': 'Morgane', 'family': 'Mailhe', 'sequence': 'additional', 'affiliation': []}, {'given': 'Barbara', 'family': 'Doudier', 'sequence': 'additional', 'affiliation': []}, {'given': 'Camille', 'family': 'Aubry', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sophie', 'family': 'Amrane', 'sequence': 'additional', 'affiliation': []}, {'given': 'Piseth', 'family': 'Seng', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marie', 'family': 'Hocquart', 'sequence': 'additional', 'affiliation': []}, {'given': 'Carole', 'family': 'Eldin', 'sequence': 'additional', 'affiliation': []}, {'given': 'Julie', 'family': 'Finance', 'sequence': 'additional', 'affiliation': []}, {'given': 'Vera Esteves', 'family': 'Vieira', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Hervé Tissot', 'family': 'Tissot-Dupont', 'sequence': 'additional', 'affiliation': []}, {'given': 'Stéphane', 'family': 'Honoré', 'sequence': 'additional', 'affiliation': []}, {'given': 'Andreas', 'family': 'Stein', 'sequence': 'additional', 'affiliation': []}, {'given': 'Matthieu', 'family': 'Million', 'sequence': 'additional', 'affiliation': []}, {'given': 'Philippe', 'family': 'Colson', 'sequence': 'additional', 'affiliation': []}, {'given': 'Bernard', 'family': 'La Scola', 'sequence': 'additional', 'affiliation': []}, {'given': 'Véronique', 'family': 'Veit', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alexis', 'family': 'Jacquier', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jean-Claude', 'family': 'Deharo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Michel', 'family': 'Drancourt', 'sequence': 'additional', 'affiliation': []}, {'given': 'Pierre Edouard', 'family': 'Fournier', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jean-Marc', 'family': 'Rolain', 'sequence': 'additional', 'affiliation': []}, {'given': 'Philippe', 'family': 'Brouqui', 'sequence': 'additional', 'affiliation': []}, {'given': 'Didier', 'family': 'Raoult', 'sequence': 'additional', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/j.tmaid.2020.101663_bib1', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ijantimicag.2020.105924', 'article-title': 'Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and ' 'coronavirus disease-2019 (COVID-19): the epidemic and the challenges', 'volume': '55', 'author': 'Lai', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents'}, { 'key': '10.1016/j.tmaid.2020.101663_bib2', 'doi-asserted-by': 'crossref', 'first-page': '727', 'DOI': '10.1056/NEJMoa2001017', 'article-title': 'A novel coronavirus from patients with pneumonia in China, 2019', 'volume': '382', 'author': 'Zhu', 'year': '2020', 'journal-title': 'N Engl J Med'}, { 'key': '10.1016/j.tmaid.2020.101663_bib3', 'series-title': "WHO Director-General's opening remarks at the media briefing on COVID-19 " '- 11 March 2020', 'year': '2020'}, { 'key': '10.1016/j.tmaid.2020.101663_bib4', 'doi-asserted-by': 'crossref', 'DOI': '10.1001/jama.2020.2648', 'article-title': 'Characteristics of and important lessons from the coronavirus disease ' '2019 (COVID-19) outbreak in China: summary of a report of 72314 cases ' 'from the Chinese center for disease control and prevention', 'author': 'Wu', 'year': '2020', 'journal-title': 'J Am Med Assoc'}, { 'key': '10.1016/j.tmaid.2020.101663_bib6', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ijantimicag.2020.105923', 'article-title': 'Chloroquine for the 2019 novel coronavirus SARS-CoV-2', 'author': 'Colson', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents'}, { 'key': '10.1016/j.tmaid.2020.101663_bib7', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ijantimicag.2020.105932', 'article-title': 'Chloroquine and hydroxychloroquine as available weapons to fight ' 'COVID-19', 'author': 'Colson', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents'}, { 'key': '10.1016/j.tmaid.2020.101663_bib8', 'doi-asserted-by': 'crossref', 'DOI': '10.1093/cid/ciaa237', 'article-title': 'In vitro antiviral activity and projection of optimized dosing design ' 'of hydroxychloroquine for the treatment of severe acute respiratory ' 'syndrome coronavirus 2 (SARS-CoV-2)', 'author': 'Yao', 'year': '2020', 'journal-title': 'Clin Infect Dis'}, { 'key': '10.1016/j.tmaid.2020.101663_bib9', 'doi-asserted-by': 'crossref', 'first-page': '16', 'DOI': '10.1038/s41421-020-0156-0', 'article-title': 'Hydroxychloroquine, a less toxic derivative of chloroquine, is ' 'effective in inhibiting SARS-CoV-2 infection in vitro', 'volume': '6', 'author': 'Liu', 'year': '2020', 'journal-title': 'Cell Discov'}, { 'key': '10.1016/j.tmaid.2020.101663_bib10', 'doi-asserted-by': 'crossref', 'first-page': '269', 'DOI': '10.1038/s41422-020-0282-0', 'article-title': 'Remdesivir and chloroquine effectively inhibit the recently emerged ' 'novel coronavirus (2019-nCoV) in vitro', 'volume': '30', 'author': 'Wang', 'year': '2020', 'journal-title': 'Cell Res'}, { 'key': '10.1016/j.tmaid.2020.101663_bib11', 'article-title': 'Focusing on the unfolded protein response and autophagy related ' 'pathways to reposition common approved drugs against COVID-19', 'author': 'Nabirothckin', 'year': '2020', 'journal-title': 'Preprints'}, { 'key': '10.1016/j.tmaid.2020.101663_bib12', 'doi-asserted-by': 'crossref', 'DOI': '10.5582/bst.2020.01047', 'article-title': 'Breakthrough: chloroquine phosphate has shown apparent efficacy in ' 'treatment of COVID-19 associated pneumonia in clinical studies', 'author': 'Gao', 'year': '2020', 'journal-title': 'Biosci Trends'}, { 'key': '10.1016/j.tmaid.2020.101663_bib14', 'article-title': 'COVID-19: a recommendation to examine the effect of hydroxychloroquine ' 'in preventing infection and progression', 'author': 'Zhou', 'year': '2020', 'journal-title': 'J Antimicrob Chemother'}, { 'key': '10.1016/j.tmaid.2020.101663_bib15', 'first-page': '185', 'article-title': 'Expert consensus on chloroquine phosphate for the treatment of novel ' 'coronavirus pneumonia', 'volume': '43', 'year': '2020', 'journal-title': 'Zhonghua Jiehe He Huxi Zazhi'}, { 'key': '10.1016/j.tmaid.2020.101663_bib16', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.ijantimicag.2020.105949', 'article-title': 'Hydroxychloroquine and azithromycin as a treatment of COVID-19: results ' 'of an open-label non-randomized clinical trial', 'author': 'Gautret', 'year': '2020', 'journal-title': 'Int J Antimicrob Agents'}, { 'key': '10.1016/j.tmaid.2020.101663_bib17', 'series-title': 'A pilot study of hydroxychloroquine in treatment of patients with common ' 'coronavirus disease-19 (COVID-19)', 'author': 'Chen', 'year': '2020'}, { 'key': '10.1016/j.tmaid.2020.101663_bib18', 'article-title': 'Efficacy of hydroxychloroquine in patients with COVID-19: results of a ' 'randomized clinical trial', 'author': 'Chen', 'year': '2020', 'journal-title': 'MedRxiv'}, { 'key': '10.1016/j.tmaid.2020.101663_bib19', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/S0140-6736(20)30566-3', 'article-title': 'Clinical course and risk factors for mortality of adult inpatients with ' 'COVID-19 in Wuhan, China: a retrospective cohort study', 'author': 'Zhou', 'year': '2020', 'journal-title': 'Lancet'}, { 'key': '10.1016/j.tmaid.2020.101663_bib20', 'doi-asserted-by': 'crossref', 'first-page': '357', 'DOI': '10.1007/s00134-020-05954-2', 'article-title': 'Novel coronavirus infection during the 2019-2020 epidemic: preparing ' 'intensive care units-the experience in Sichuan Province, China', 'volume': '46', 'author': 'Liao', 'year': '2020', 'journal-title': 'Intensive Care Med'}, { 'key': '10.1016/j.tmaid.2020.101663_bib21', 'first-page': '25', 'article-title': 'Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR', 'author': 'Corman', 'year': '2020', 'journal-title': 'Euro Surveill'}, { 'key': '10.1016/j.tmaid.2020.101663_bib22', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.tmaid.2020.101632', 'article-title': 'Rapid viral diagnosis and ambulatory management of suspected COVID-19 ' 'cases presenting at the infections diseases referral hospital in ' 'Marseille, France, -January 31st to March 1st, 2020: a respiratory ' 'virus snapshot', 'author': 'Amrane', 'year': '2020', 'journal-title': 'Trav Med Infect Dis'}, { 'key': '10.1016/j.tmaid.2020.101663_bib23', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/S1473-3099(20)30196-1', 'article-title': 'Temporal profiles of viral load in posterior oropharyngeal saliva ' 'samples and serum antibody responses during infection by SARS-CoV-2: an ' 'observational cohort study', 'author': 'To', 'year': '2020', 'journal-title': 'Lancet'}, { 'key': '10.1016/j.tmaid.2020.101663_bib24', 'article-title': 'Viral dynamics in mild and severe cases of COVID-19', 'author': 'Liu', 'year': '2020', 'journal-title': 'Lancet Infect Dis'}, { 'key': '10.1016/j.tmaid.2020.101663_bib25', 'doi-asserted-by': 'crossref', 'DOI': '10.1164/rccm.202003-0524LE', 'article-title': 'Time kinetics of viral clearance and resolution of symptoms in novel ' 'coronavirus infection', 'author': 'Chang', 'year': '2020', 'journal-title': 'Am J Respir Crit Care Med'}, { 'key': '10.1016/j.tmaid.2020.101663_bib26', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/S2214-109X(20)30114-5', 'article-title': 'Use of antiviral drugs to reduce COVID-19 transmission', 'author': 'Mitja', 'year': '2020', 'journal-title': 'Lancet Glob Health'}, { 'key': '10.1016/j.tmaid.2020.101663_bib27', 'doi-asserted-by': 'crossref', 'first-page': '919', 'DOI': '10.1007/s40264-018-0689-4', 'article-title': 'Cardiac complications attributed to chloroquine and hydroxychloroquine: ' 'a systematic review of the literature', 'volume': '41', 'author': 'Chatre', 'year': '2018', 'journal-title': 'Drug Saf'}, { 'key': '10.1016/j.tmaid.2020.101663_bib28', 'doi-asserted-by': 'crossref', 'first-page': '1461', 'DOI': '10.1056/NEJMc1212055', 'article-title': 'U.S. outpatient antibiotic prescribing, 2010', 'volume': '368', 'author': 'Hicks', 'year': '2013', 'journal-title': 'N Engl J Med'}], 'container-title': 'Travel Medicine and Infectious Disease', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S1477893920301319?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S1477893920301319?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2022, 7, 13]], 'date-time': '2022-07-13T01:55:27Z', 'timestamp': 1657677327000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S1477893920301319'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2020, 3]]}, 'references-count': 26, 'alternative-id': ['S1477893920301319'], 'URL': 'http://dx.doi.org/10.1016/j.tmaid.2020.101663', 'relation': {}, 'ISSN': ['1477-8939'], 'subject': [], 'container-title-short': 'Travel Medicine and Infectious Disease', 'published': {'date-parts': [[2020, 3]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Clinical and microbiological effect of a combination of hydroxychloroquine and ' 'azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot ' 'observational study', 'name': 'articletitle', 'label': 'Article Title'}, { 'value': 'Travel Medicine and Infectious Disease', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.tmaid.2020.101663', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, { 'value': '© 2020 Elsevier Ltd. All rights reserved.', 'name': 'copyright', 'label': 'Copyright'}], 'article-number': '101663'}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit